Clinical Trial Update: Non-Ablative Allo HSCT For Hematologic Malignancies or SAA [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating non-ablative allogeneic hematopoietic stem cell transplantation for hematologic malignancies and severe aplastic anemia; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Leukemia
• Lymphoma
• Multiple Myeloma and Plasma Cell Neoplasms
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms
• Small Intestine Cancer

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Chronic Myeloproliferative Disorders, Leukemia | Phase 2 | Status: COMPLETED